Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization.
Esteban Fernández A, Recio Mayoral A, González Franco A, Núñez Villota J, Mirabet S, Rubio Gracia J, González Costello J, Bonilla Palomas JL, Escobar Cervantes C. Esteban Fernández A, et al. Among authors: escobar cervantes c. Expert Opin Pharmacother. 2023 Apr;24(6):705-713. doi: 10.1080/14656566.2023.2195540. Epub 2023 Mar 31. Expert Opin Pharmacother. 2023. PMID: 36961877 Review.
Identifying the patient with heart failure to be treated with vericiguat.
Escobar Cervantes C, Esteban Fernández A, Recio Mayoral A, Mirabet S, González Costello J, Rubio Gracia J, Núñez Villota J, González Franco Á, Bonilla Palomas JL. Escobar Cervantes C, et al. Curr Med Res Opin. 2023 May;39(5):661-669. doi: 10.1080/03007995.2023.2189857. Epub 2023 Mar 23. Curr Med Res Opin. 2023. PMID: 36897009 Review.
Benefits of dapagliflozin in the whole spectrum of heart failure in clinical practice: the RICA registry.
Montero-Pérez-Barquero M, Escobar-Cervantes C, Dávila-Ramos MF, Suárez-Pedreira I, Pérez-Silvestre J, Ceresuela-Eito LM, Muela-Molinero A, Quesada-Simón MA, Formiga F, González-Franco A, Casado-Cerrada J. Montero-Pérez-Barquero M, et al. Among authors: escobar cervantes c. Future Cardiol. 2023 May;19(6):323-332. doi: 10.2217/fca-2023-0014. Epub 2023 Jun 29. Future Cardiol. 2023. PMID: 37382089
Projected clinical benefits of dapagliflozin in patients with heart failure with preserved ejection fraction.
Montero-Pérez-Barquero M, Escobar-Cervantes C, Llàcer P, Quirós-López R, Trullás JC, Cerqueiro JM, Epelde-Gonzálo F, Carrera-Izquierdo M, Formiga F, González-Franco A, Casado-Cerrada J. Montero-Pérez-Barquero M, et al. Among authors: escobar cervantes c. Future Cardiol. 2023 May;19(6):333-342. doi: 10.2217/fca-2023-0015. Epub 2023 Jun 29. Future Cardiol. 2023. PMID: 37382199
Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice.
Montero-Pérez-Barquero M, Escobar-Cervantes C, Arévalo-Lorido JC, Conde-Martel A, Salamanca-Bautista P, Manzano-Espinosa L, Formiga F, Díez-Manglano J, Cepeda JM, González-Franco A, Casado-Cerrada J. Montero-Pérez-Barquero M, et al. Among authors: escobar cervantes c. Future Cardiol. 2023 May;19(6):343-351. doi: 10.2217/fca-2023-0016. Epub 2023 Jun 29. Future Cardiol. 2023. PMID: 37382223
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes.
Castro Conde A, Marzal Martín D, Campuzano Ruiz R, Fernández Olmo MR, Morillas Ariño C, Gómez Doblas JJ, Gorriz Teruel JL, Mazón Ramos P, García-Moll Marimon X, Soler Romeo MJ, León Jiménez D, Arrarte Esteban V, Obaya Rebollar JC, Escobar Cervantes C, Gorgojo Martínez JJ. Castro Conde A, et al. Among authors: escobar cervantes c. J Clin Med. 2023 Jun 8;12(12):3925. doi: 10.3390/jcm12123925. J Clin Med. 2023. PMID: 37373620 Free PMC article. Review.
94 results